You can now measure your risk of Alzheimer’s before symptoms appear.

pTau217 and A𝛃42 are recent FDA-approved biomarkers for Alzheimer's detection in symptomatic patients. They also predict future dementia risk in healthy individuals, according to recent studies. 🧵